Compared to those in the tumor-bearing control, ATRA treatment alone upregulated the levels of Th2 cells and Tregs (Figure 4B), which suggested that ATRA treatment alone could not enhance the CD4+ T-cell-mediated antitumor immune response but could induce immunosuppression. The gene discussed is CD4; the disease is neoplasm.